Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letermovir vs Valganciclovir for CMV Prevention in Heart Transplant Recipients
NCT07079735Phase 3Recruiting
- Sponsor
- Columbia University
- Start
- Sep 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of letermovir, sponsored by Columbia University. Started Sep 2025; status: recruiting.
02
Drugs
letermovir
Beyond the preview
Go deeper on NCT07079735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07079735.